Medical Case Reports

Using a unique dataset from Israel National Emergency Medical Services (EMS) from 2019 to 2021, a n increase of over 25% was detected in both  cardiac arrest (CA) and acute coronary syndrome (ACS) EMS calls  during January–May 2021, compared with the years 2019–2020.  This study leveraged the Israel National EMS (IEMS) data system and analyzed all calls related to CA and ACS events over two and a half years, from January 1st, 2019, throughout June 20th, 2021. U sing Negative Binomial regression models, the weekly emergency call counts were significantly associated with the rates of 1st and 2nd vaccine doses administered to this age group but were not with COVID-19 infection rates.  These findings are emphasized by Figures  that present the graphs described in the “ Methods ” section for both CA and ACS, CA only, and ACS only, respectively. Both the CA and ACS call counts (red curve) start increasing early January 2021 and seem to track closely the 2nd dose curve (solid blue curve). Th

It’s heartbreaking what is happening in society right now . A 15-year-old boy enrolled at a prestigious private school had a promising future — that is, until his parents say he became a victim of relentless cyberbullying by his classmates. He  was initially targeted by a false rumor that he was unvaccinated. He was bullied relentlessly until he took his own life in January . The lawsuit filed on April 25, 2022 against the  Latin School of Chicago  alleges administrators at the private college prep school committed “willful failure” to stop the incessant bullying,  the Chicago Tribune reported . The Cook County filing named the school, several employees and parents of the alleged bullies as defendants. The late teen transferred to the school due to its in-person learning during the coronavirus pandemic, the complaint states. A student whose parents are named in the lawsuit then started spreading a rumor that the 10th-grader, Nate Bronstein, was unvaccinated, according to the lawsuit. N

A 43-year-old man who had malignant melanoma (pT3bN1bM0 stage IIIC) received nivolumab treatment (480 mg 1× every 4 wks) 12 months before admission. Fasting plasma glucose level was 94 mg/dL and glycated hemoglobin (HbA1c) 5.6% at treatment initiation. Plasma glucose and HbA1c were tested every 4 weeks. His range of plasma glucose was 90–123 mg/dL and that of HbA1c was 5.4%–5.7% ( Figure ). Positron emission tomography–computed tomography showed no metastasis or recurrence of the tumor 1 month before admission. The man received his first SARS-CoV-2 vaccination 35 days before admission. No apparent adverse reactions occurred, except for local pain. The last nivolumab dose was administered 21 days before admission and the second SARS-CoV-2 vaccination 14 days before admission. The next day, he had a slight fever (temperature 37°C), which soon subsided. Thirst, polydipsia, and polyuria appeared 2 days after the second vaccination. He started drinking 3 L of water/day, and his weight decre

To examine the possible non-specific effects of the novel COVID-19 vaccines, the authors of this study  (to be published in Lancet) reviewed the randomized control trials (RCTs) of mRNA and adenovirus-vector COVID-19 vaccines reporting overall mortality, including COVID-19 deaths, accident deaths, cardiovascular deaths and other non-COVID-19 deaths. For overall mortality, with 74,193 participants and 61 deaths (mRNA:31; placebo:30), the relative risk (RR) for the two mRNA vaccines compared with placebo was 1.03 (95% CI=0.63-1.71).  There is now ample evidence that vaccines can not only add protection but also increase susceptibility to unrelated infections or even other non-infectious immune mediated diseases.  Analysis of the final study reports from vaccine clinical trials found the vaccines had no effect on overall mortality. Among 74,000 trial participants, at 6 months follow-up, there were 31 all-cause deaths among the vaccinated (n=37,110) and 30 among the placebo groups 

The Accident Compensation Corporation ( ACC ) of New Zealand has accepted 987 claims for injuries relating to the Covid-19 vaccine, and 68% of those are women. Between the beginning of New Zealand’s vaccine program in February 2021 and April 2, 2022, ACC received 2522 claims, with 987 being accepted, and 297 are still pending. During this period, ACC paid out $1.12 million in compensation.  ACC had accepted 186 claims related to allergic reactions, 103 claims for sprains, 102 claims for contusions. There were 77 accepted claims for cardiac injury, such as myocarditis or pericarditis. In terms of age, the group that lodged the greatest number of claims were those in the 45-49 age bracket. Ethnicity data showed 71% of claims lodged with ACC were from Pākehā, and 9% Māori. Of the 1238 rejected claims, 973 were turned down because ACC deemed there was no injury, and in 119 cases there was no causal link to the vaccine. Three claims have been made for fatal injury – all due to myocarditis a

 A 54-year-old  woman  received second dose of an mRNA vaccine on June 28th and her third booster dose on December 22, 2021 She tested positive for COVID-19 on January 2nd 2022 followed by two negative tests by January 6th.  However, she was still sick in February and March suffering from  “debilitating fatigue and heart problems.”  When spoking with News.com on April 15,  she reported being bedridden for two weeks in January. Thereafter she developed bladder inflammation. She revealed that she has pericarditis, which makes it hard for her to walk or even get out of bed. She also reported severe chest pains that landed her in the hospital because she thought she was having a heart attack. She can no longer exercise or take walks with friends. REFERENCES Long Covid: Tracey Spicer has debilitating long COVID, 'Shadow of my former self' | Exclusive (9news.com.au) Tracey Spicer details horror effects of long Covid after contracting virus in January (dailymail.co.uk) Tracey Spicer:

A New Zealand man has died on November 17, 2021, after the Pfizer Covid-19 vaccine 'probably' caused a rare heart problem, authorities have revealed. This happened less than two weeks after taking his first dose on November 5.  A preliminary postmortem examination identified myocarditis, a rare inflammation of the heart muscle, as the likely cause of death and New Zealand's Covid-19 Vaccine Independent Safety Monitoring Board said the issue was 'probably' brought on by the jab. He started feeling 'flutters' a few hours after having his first dose of the vaccine but dismissed the symptoms as stress-related because he was in the process of selling and buying a house as well as planning a wedding. Around 3am on November 17, the couple decided to go to hospital for 'reassurance' but he collapsed while getting ready to go in the bathroom and was later pronounced dead.    The death is only New Zealand's second linked to a known but rare side effect fro

On September 2 of 2020,  Vladimir Zhirinovsky, the leader of the Liberal Democratic Party (LDPR) of Russia, received his first dose of COVID-19 vaccine - as a participant of  Gam-COVID-Vac  (Sputnik V)  clinical trials. 3 weeks later he got the second dose with no side effects.  Sputnik V ( Спутник V ) is an  adenovirus   viral vector vaccine   for COVID-19  developed by the  Gamaleya Research Institute of Epidemiology and Microbiology  in  Russia . It is the world's first registered  combination vector vaccine  for the prevention of COVID-19, having been registered on 11 August 2020 by the  Russian Ministry of Health .  Gam-COVID-Vac was initially approved for distribution in Russia and then in at least 59 other countries on the preliminary results of  Phase I – II  studies eventually published on 4 September 2020.  Both doses of Sputnik V contain non-replicating viral vectors. The first component uses adenovirus type 26 (AD26), and the second — which a person receives 21 days la

COVID-19 vaccines reduce hospitalization and death, but they don't completely eliminate it. Why are not we studying the fatal cases, to help those not protected by the existing vaccines? Latest report from Public Health Ontario mentions 24 individuals 70 years of age and older that died from COVID-19 despite receiving 4 doses of COVID-19 vaccines. Yes, this is a much smaller number compared to the number of people who died after 3 doses, but since many vulnerable individuals  have already died from COVID-19 and many of vaccine-sensitive/virus vulnerable persons were not able to get additional shots, isn't it time to look into this instead of keeping increasing the number of mandated doses?  REFERENCE ENHANCED EPIDEMIOLOGICAL SUMMARY Confirmed Cases of COVID-19 Following Vaccination in Ontario: December 14, 2020 to March 27, 2022